Methyl 5-hydroxy-4-oxo-4H-pyran-2-carboxylate was synthesized by esterification of methanol with comenic acid under acidic catalysis. The obtained ester was alkylated with 3-(chloromethyl)-5-phenylisoxazole and 4,5-dichloro-3-(chloromethyl)isothiazole to afford corresponding conjugates containing isoxazole and isothiazole moieties which then were transformed into water-soluble Li-salts. During the bioassays of synthesized isoxazole and isothiazole derivatives of comenic acid in mixtures with first-line antitumor drug Temobel (Temozolomid) used in brain tumors chemotherapy, a synergetic effect was observed.
AidaKō. (1955) Studies on oxidative fermentation. Part XII. On the formation of rubiginic acid, a new γ-pyrone derivative, and comenic acid, by Gluconoacetobacter liquefaciens.Bulletin Agricultural Chemical Society, Japan, 19, 97–103.
2.
BentleyR. (2006) From miso, saké and shoyu to cosmetics: a century of science for kojic acid. Natural Product Reports, 23, 1046–1062.
3.
IchimotoI., TatsumiCh. (1970) Hydroxyethylation of comenic acid. Synthesis of ethyl-maltol from comenic Acid. Agricultural and Biological Chemistry, 34, 961–963.
4.
ChisvertA., SisternesJ., BalaguerA., SalvadorA. (2010;) A gas chromatography-mass spectrometric method to determine skin-whitening agents in cosmetic products. Talanta, 81, 530–536.
5.
EmamiS., HosseinimehrS.J., TaghdisiS.M., AkhlaghpoorS. (2007) Kojic acid and its manganese and zinc complexes as potential radioprotective agents. Bioorganic & Medicinal Chemistry Letters, 17, 45–48.
6.
OzturkG., ErolD.D., AyrtemirD.D., UzbayT. (2002) New analgesic and anti-inflammatory agents 4(1H)-pyridinone derivatives. European Journal of Medicinal Chemistry, 37, 829–834.
7.
KimJ.H., CampbellB.C., ChanK.L., MahoneyN., HaffR.P. (2013) Synergism of antifungal activity between mitochondrial respiration inhibitors and kojic acid. Molecules. 18, 1564–1581.
8.
ShuryginaL.V., ZlishchevaE.I., KhablyukV.V., KravtsovaA.N., AbramovaN.O., ZlishchevaL.I., KravtsovA.A. (2015) Comparative analysis of antioxidant properties of comenic acid and potassium comenate in modeled immobilization stress. Bulletin of Experimental Biology and Medicine, 159, 457–459.
9.
DerbenevA.V., KrylovB.V., ShuryginAYa. (2000) Effects of meconic and comenic acids on slow sodium channels of secondary neurons. Membrane & Cell Biology, 13, 379–387.
10.
ShuryginaL.V., ZlishchevaE.I., KravtsovA.A. (2018) Neurotrophic action of comenic acid and its derivatives potassium comenate and calcium comenate. Bulletin of Experimental Biology and Medicine, 165, 465–469.
11.
ShuryginaL.V., ZlishchevaE.I., KravtsovA.A., SkorokhodN.S., AbramovaN.O. (2017) Neuroprotective effect of calcium comenate under oxidative stress and glutamate cytotoxicity on the model of cultured cerebellar neurons and spinal ganglia neurons. Eksperimental'naya i Klinicheskaya Farmakologiya, 80, 6–10.
12.
ShuryginaL.V., ZlishchevaE.I., KravtsovaA.N., KravtsovA.A. (2017) Antioxidant and antiamnestic effects of potassium comenate and comenic acid under conditions of normobaric hypoxia with hypercapnia. Bulletin of Experimental Biology and Medicine, 163, 344–348.
13.
KrylovB.V., ShchegolevB.F. (2003) Substance of sedative action. Russian patent 22090621.
14.
KrylovB.V., LopatinaE.V. (2009) Analgesic agent and therapy of pain syndrome of various aetiologies by using said agent. Russian patent 2367432.
15.
KulchitskyV.A., PotkinV.I., ZubenkoYuS, ChernovA.N., TalabaevM.V., DemidchikYuE, PetkevichS.K., KazbanovV.V., GurinovichT.A., RoevaM.O., GrigorievD.G., KletskovA.V., KalunovV.N. (2012) Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroephitelium tumors. Medicinal Chemistry, 8, 22–32.
16.
PotkinV.I., KletskovA.V., PetkevichS.K., PashkevichS.G., KazbanovV.V., DenisovA.A., KulchitskyV.A. (2015) Synthesis of water soluble isoxazol-3-yl(isothiazol-3-yl) carboxamides and ureas containing amino acid residues – potential anticancer agents. Heterocyclic Letters, 1, 11–19.
17.
PotkinV., ZubenkoYu, BykhovetzA., ZolotarR., GoncharukV. (2009) Synthesis of novel vanillin derivatives containing isothiazole moieties and its synergistic effect in mixtures with insecticides. Natural Product Communications, 4, 1205–1208.
18.
KletskovA.V., PotkinV.I., DikusarE.A., ZolotarR.M. (2017) New data on vanillin-based isothiazolic insecticides synergists. Natural Product Communications, 12, 105–106.
19.
MatzenL., EngesgaardA., EbertB., DidriksenM., FrolundB., Krogsgaard-LarsenP., JaroszewskiJ.W. (1997) AMPA receptor agonists. Synthesis, protolytic properties and pharmacology of 3-isothiazole bioisosteres of glutamic acid. Journal of Medicinal Chemistry, 40, 521–527.
20.
ZefirovaO.N., ZefirovN.S. (2000) Physiologically active compounds interacting with glutamate receptors. Russian Journal of Organic Chemistry, 36, 1231–1258.
21.
PotkinV.I., PetkevichS.K., KletskovA.V., DikusarE.A., Zubenko YuS., ZhukovskayaN.A., KazbanovV.V., PashkevichS.G. (2013) Synthesis of functionally substituted isoxazole and isothiazole derivatives. Russian Journal of Organic Chemistry, 49, 1523–1533.
22.
PotkinV.I., BumaginN.A., PetkevichS.K., DikusarE.A., SemenovaE.V., KurmanP.V., Zolotar’R.M., PashkevichSG., GurinovichT.A., Kul'chitskiiV.A. (2015) Synthesis of functional isoxazole derivatives proceeding from (5-arylisoxazol-3-yl)chloromethanes. Russian Journal of Organic Chemistry, 51, 1119–1130.
23.
BeyaertR., VanhaesebroeckB., SuffysP., Van RoyF., FiersW. (1989) Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America, 86, 9494–9498.
24.
PietuchA., BrücknerB.R., SchneiderD., TarantolaM., RosmanCh, SönnichsenC., JanshoffA. (2015) Mechanical properties of MDCK II cells exposed to gold nanorods. Beilstein Journal of Nanotechnology, 6, 223–231.
25.
KulchitskyV.A., AlexandrovaR., SuziedelisK., PaschkevichS.G., PotkinV.I. (2014) Perspectives of fullerenes, dendrimers, and heterocyclic compounds application in tumor treatment. Recent Patents on Nanomedicine, 4, 82–89.